Panic Disorder Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceActs as second messenger in serotonin system; significantly reduces panic attack frequency in clinical trials
Proprietary lavender extract with demonstrated anxiolytic effects comparable to low-dose benzodiazepines
Supporting Stack
Additional supplements for enhanced resultsModulates GABA and glutamate; deficiency associated with anxiety; supplementation may reduce panic symptoms
Supporting Studies (1)
Amino acid from tea that increases alpha brain waves and promotes calm without sedation
Supporting Studies (1)
GABA-ergic herb with anxiolytic effects; may help with acute anxiety symptoms
Supporting Studies (1)
Adaptogen that reduces cortisol and anxiety; may help with chronic stress component of panic
Supporting Studies (1)
Anti-inflammatory effects on brain; may reduce anxiety symptoms
Supporting Studies (1)
Deficiency associated with anxiety; vitamin D receptors in brain regions involved in mood
Supporting Studies (1)
Support neurotransmitter synthesis; may help with stress resilience
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Panic disorder is characterized by recurrent, unexpected panic attacks - sudden surges of intense fear or discomfort with physical symptoms like racing heart, shortness of breath, chest pain, dizziness, and fear of dying or losing control. People with panic disorder often develop anticipatory anxiety (fear of the next attack) and may avoid situations where attacks have occurred. It affects about 2-3% of the population and is highly treatable with therapy and/or medication.
CRITICAL: Panic attacks can mimic serious medical conditions like heart attacks. New or severe symptoms should be medically evaluated. Panic disorder responds very well to Cognitive Behavioral Therapy (CBT), which is considered first-line treatment. SSRIs and benzodiazepines are effective medications. These supplements may help but should not delay evidence-based treatment. If panic attacks are frequent or impairing your life, see a mental health professional.
* Inositol has the strongest supplement evidence for panic disorder. It works through the serotonin system similar to SSRIs. Clinical trials show high-dose inositol (12-18g/day) significantly reduces panic attack frequency, comparable to fluvoxamine. Start with lower doses to avoid GI side effects.
* Lavender Oil (Silexan) is a standardized lavender extract with proven anxiolytic effects. Multiple trials show it reduces anxiety comparable to low-dose lorazepam but without sedation or dependence risk.
* Magnesium deficiency is associated with increased anxiety. Magnesium modulates GABA (the calming neurotransmitter) and supplementation may help reduce panic symptoms.
* L-Theanine is an amino acid from green tea that increases calming alpha brain waves. It promotes relaxation without sedation and can be taken as needed for acute anxiety.
* Passionflower has GABA-ergic effects and may help with acute anxiety symptoms.
* Ashwagandha is an adaptogen that reduces cortisol levels. It may help address the chronic stress component of panic disorder.
* Omega-3 Fatty Acids have anti-inflammatory effects on the brain and may help reduce anxiety symptoms.
* Vitamin D deficiency is associated with anxiety disorders. Maintaining adequate levels supports overall mental health.
* B Vitamins support neurotransmitter synthesis and stress resilience.
Expected timeline: Inositol: 4-8 weeks for full effect. Lavender: 2-4 weeks. L-theanine and passionflower: can work acutely. Magnesium: 4-8 weeks for nervous system support. CBT typically shows improvement in 12-16 sessions.
Clinical Perspective
Panic disorder: recurrent unexpected panic attacks (sudden surge of fear/discomfort with 4+ symptoms: palpitations, sweating, trembling, SOB, choking, chest pain, nausea, dizziness, derealization, fear of losing control/dying, paresthesias, chills/hot flashes) plus persistent concern about additional attacks, worry about implications, or maladaptive behavior change. Lifetime prevalence 2-3%. 2:1 female:male. Often comorbid with agoraphobia, depression, substance use.
CRITICAL: Rule out medical causes (cardiac arrhythmia, hyperthyroidism, pheochromocytoma, substance-induced). First-line treatment: CBT (particularly panic-focused CBT with interoceptive exposure) and/or SSRIs/SNRIs. Benzodiazepines for acute/bridge but not long-term due to dependence. Supplements are ADJUNCTIVE - should not delay evidence-based treatment. Response rates with proper treatment >80%.
* Inositol (A-grade): Phosphoinositide second messenger; affects serotonin receptors. Double-blind trial: 12g/day equivalent to fluvoxamine for panic (PMID: 7793450). Clinical trial: reduced panic attacks and agoraphobia (PMID: 11386498). 12-18g daily in divided doses. GI upset at higher doses.
* Lavender (Silexan) (B-grade): Standardized lavender oil (Lasea); affects voltage-dependent calcium channels. Meta-analysis: effective for anxiety disorders (PMID: 25831293). Randomized trial: comparable to lorazepam (PMID: 24456909). 80-160mg daily. No sedation or dependence.
* Magnesium (B-grade): GABA modulation, NMDA receptor blocking. Systematic review: anxiety benefit particularly with other symptoms (PMID: 28445426). 300-400mg daily. Glycinate or threonate for CNS effects.
* L-Theanine (B-grade): Increases alpha waves; GABA and glutamate modulation. Clinical trial: reduced anxiety (PMID: 16930802). 100-400mg daily or PRN. Non-sedating.
* Passionflower (B-grade): GABA-A receptor binding. Systematic review: comparable to benzodiazepines for acute anxiety (PMID: 18499602). 250-500mg extract daily or PRN.
* Ashwagandha (B-grade): Adaptogen; reduces cortisol. Randomized trial: reduced anxiety and stress (PMID: 23439798). 300-600mg standardized extract daily.
* Omega-3 Fatty Acids (C-grade): Anti-inflammatory; affect neurotransmitter function. Meta-analysis: modest anxiolytic effect (PMID: 29954199). 2-3g EPA+DHA daily.
* Vitamin D (C-grade): VDR in limbic system. Systematic review: deficiency associated with anxiety (PMID: 28750018). Target 40-60 ng/mL.
* B Vitamins (C-grade): Cofactors in neurotransmitter synthesis. Review: may reduce stress and anxiety (PMID: 30213578). B-complex with adequate B6, B12, folate.
Biomarker targets: Panic Disorder Severity Scale (PDSS), Agoraphobic Cognitions Questionnaire, Anxiety Sensitivity Index, functional impairment measures, vitamin D level.
Protocol notes: CBT is gold standard - education, cognitive restructuring, interoceptive exposure (simulating panic sensations), in vivo exposure for avoidance. SSRIs (sertraline, paroxetine, fluoxetine) or SNRIs (venlafaxine) are first-line medications; start low, titrate slowly. Benzodiazepines: fast acting but dependence risk; use for acute attacks or short-term bridge. Avoid chronic benzodiazepine use. TCAs effective but more side effects. Respiratory training helpful. Exercise has anxiolytic effects. Limit caffeine, alcohol. Sleep optimization. Address comorbid depression. Agoraphobia requires specific exposure therapy. Medication typically continued 6-12 months after remission then gradual taper. Relapse prevention skills important. Support groups. Some patients benefit from combined medication + CBT.